BridgeMD
New treatment option for Uncontrolled Hypertension
Official title Remote Hypertension Management for Black Patients
ClinicalTrials.gov ID: NCT06527794
What this study is testing
- What it's testing
- This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 85
You may be able to join if
- Black or African American race
- Hypertension diagnosis
- aged 21 to 85 years
- Uncontrolled blood pressure as defined by [a] most recent SBP ≥140 mmHg and an additional SBP≥140 mmHg within the past 12 months in an outpatient...
- Able to speak English
You likely can't join if
- currently pregnant or planning to get pregnant during the study period
- residence in a long-term care facility, hospice or with a terminal illness with less than 1 year life expectancy as determined by the Primary Care...
- estimated Glomerular Filtration Rate (eGFR) \<30 ml/min or on dialysis. Patients with a functioning kidney transplant will not be excluded.
- inability to provide informed consent or participate in study procedures. For example, conditions that limit ability to participate in phone visits...
- currently participating in another BP management program.
- plan to move out of the area within the next 12 months.
See the full eligibility criteria
- Black or African American race
- Hypertension diagnosis
- aged 21 to 85 years
- Uncontrolled blood pressure as defined by [a] most recent SBP ≥140 mmHg and an additional SBP≥140 mmHg within the past 12 months in an outpatient setting (excluding urgent care, emergency department or surgery clinic)...
- Able to speak English
- Primary care provided at a participating clinic
- currently pregnant or planning to get pregnant during the study period
- residence in a long-term care facility, hospice or with a terminal illness with less than 1 year life expectancy as determined by the Primary Care Physician or study team. Stable chronic illness such as compensated...
- estimated Glomerular Filtration Rate (eGFR) \<30 ml/min or on dialysis. Patients with a functioning kidney transplant will not be excluded.
- inability to provide informed consent or participate in study procedures. For example, conditions that limit ability to participate in phone visits or check BPs in at least one arm.
- currently participating in another BP management program.
- plan to move out of the area within the next 12 months.
- Hispanic ethnicity.
The study team makes the final eligibility decision.
Where it's taking place
- Winston-Salem, North Carolina, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Winston-Salem, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.